Inhibikase Therapeutics Inc (NAS:IKT)
$ 2.65 0.04 (1.53%) Market Cap: 174.30 Mil Enterprise Value: 164.24 Mil PE Ratio: 0 PB Ratio: 3.73 GF Score: 40/100